Since CD47 can competitively occupy SIRPα, the overexpression of CD47 on T-EVs may disrupt CD47/SIRPα signal and lead to enhanced macrophage-mediated phagocytosis of tumor cells 110. The gene discussed is SIRPA; the disease is neoplasm.